Elang Mahkota Teknologi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Elang Mahkota Teknologi Tbk. trades at Rp515 (market cap 31.94T, 23.61M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Elang Mahkota Teknologi Tbk. is far larger — about 54.6× UBC Medical Indonesia Tbk.'s market cap, and Elang Mahkota Teknologi Tbk. is more actively traded (23.61M versus 817.3K). Which is the better fit depends on your goals.
| EMTK | LABS | |
|---|---|---|
Market Cap | 31.94T | 584.6B |
Volume | 23.61M | 817.3K |
Lot | 236.13K | 8.17K |
Turnover | 12.22B | 120.01M |
Average Price | 517.66 | 146.84 |
Value | 12.22B | 120.01M |
Indicative Equilibrium Price | 515 | 146 |
Indicative Equilibrium Volume | 8.64K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Read more on EMTK →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →